Abstract Background In French Guiana, cervical cancer is the second most frequent cancer
in females. The objective of the present study was to describe the prevalence of HPV …

OBJECTIVE:: To study the prevalence of high-risk human papillomavirus (HR-HPV) types 16
and 18 in healthy women with negative Pap smears in identifying women with underlying …

Human papillomavirus (HPV) DNA testing is replacing cervical cytology as a primary
cervical cancer screening tool. The aim of this study was to determine the frequency of …

As a part of the long-term prospective follow-up study conducted for women with genital
human papillomavirus (HPV) infections in Kuopio University Hospital, Finland, since 1981, a …

Background. Diagnoses of genital warts (GW) in genitourinary medicine (GUM) clinics have
been increasing in England for many years. In 2008, an HPV immunization program began …

Background: To determine differences in the seroprevalence of high-risk human
papillomavirus (hrHPV) types between men having sex with men (MSM), heterosexual men …

A breakthrough in oncology was the demonstration of the association of cervical and other
genital infections with squamous neoplasia.*,* Further studies established the molecular …

Abstract The prospective Finnish Family HPV Study evaluated the dynamics of human
papillomavirus (HPV) infection within families. Here, we focused on HPV serology in men …

Background Most individuals are infected with human papillomavirus (HPV) at least once in
their lifetime. Infections with low-risk types can cause genital warts, whereas high-risk types …

Infection of genital and anal epithelia by human papilloma viruses (HPV) may be expressed
as clinical or subclinical disease, or it may be latent. Anogenital warts are clinically obvious …